A Study Comparing BL-B01D1 With Chemotherapy of Physician ' s Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: BL-B01D1; Drug: Irinotecan; Drug: paclitaxel; Drug: docetaxel Sponsors: Sichuan Baili Pharmaceutical Co., Ltd.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials